Results 31 to 40 of about 64,235 (269)

Endoscopic yield of chronic dyspepsia in outpatients: A single‐center experience in Cambodia

JGH Open, 2020
Background and Aim The diagnostic evaluation and management of patients with chronic dyspepsia may differ geographically according to patient age, prevalence of Helicobacter pylori or parasitic infection, and risk of gastric cancer.
Borathchakra Oung, Khang Chea, Chakravuth Oung, Jean‐Christophe Saurin, Cynthia W Ko   +4 more
doaj   +1 more source

Association between Anxiety and Dyspepsia among Outpatients at Atma Jaya Hospital

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Background: Anxiety is a psychological condition characterized by excessive fear and worry that occurs continuously and is difficult to control. Anxiety play a significant role in causing dyspepsia through the Brain-Gut Axis mechanism.
Samantha Yaffa Heryadi, Riki Tenggara, Eva Suryani, Nelly Tina Widjaja, Nicholas Hardi   +4 more
doaj   +1 more source

Is Endoscopy Really Necessary in My Case? A Four Year Retrospective Study [PDF]

Journal of Clinical and Diagnostic Research, 2015
Introduction: About 40% of the general population report dyspepsia at some time in their life making it a fairly common disease. Uncomplicated dyspepsia refers to patients whose dyspepsia is not accompanied by alarm features or associated with NSAIDS
HN Dinesh, CD Jagadish Kumar, HM Sanjay, V Sachin, Basavaraju   +4 more
doaj   +1 more source

The Role of Gastrointestinal Microbiota in Functional Dyspepsia: A Review

Frontiers in Physiology, 2022
Functional dyspepsia is a clinically common functional gastrointestinal disorder with a high prevalence, high impact and high consumption of medical resources.
Li Zhou, Yi Zeng, Hongxing Zhang, Yan Ma
doaj   +1 more source

Functional dyspepsia in Yola, Nigeria [PDF]

, 2016
Objective: Dyspepsia is a common disorder originating from the upper gastrointestinal tract, and is the most common indication for gastrointestinal endoscopy.
Salawu, F.K., Vickola, J.A., Olokoba, A.B.   +2 more
core   +1 more source

Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mosliciguat (BAY 1237592), the first soluble guanylate cyclase (sGC) activator in a dry powder inhaler (DPI), could potentially treat pulmonary hypertension with a more targeted delivery than systemic sGC stimulators. We report safety and tolerability of mosliciguat in healthy men.
Johannes Nagelschmitz, Soundos Saleh, Sandra Ligges, Melanie Seidel‐Greven, Eva Becker‐Pelster, Sylvia M. Nikkho, Stefanie Boxnick, Wolfgang Timmer   +7 more
wiley   +1 more source

Transabdominal Ultrasound of the Stomach in Patients with Functional Dyspepsia: A Review

Diagnostics
Background/Aim: Dyspepsia is a very common condition worldwide and has an immense impact on quality of life. Functional dyspepsia (FD) is defined by dyspeptic symptoms with the absence of any structural abnormality that can explain the cause ...
Sangeeta Roopan, Odd Helge Gilja
doaj   +1 more source

Helicobacter pylori and functional dyspepsia: Review of previous studies and commentary on new data

, 2002
Many studies have attempted to prove a link between Helicobacter pylori infection and functional dyspepsia but the results have been conflicting. Several mechanisms have been postulated for how H pylori associated inflammation disturbs antral and ...
Pozzato P., Zagari R. M., Fossi S., Roda E., Berretti D., Bazzoli F., De Luca L., Nicolini G., Ricciardiello L.   +8 more
core   +1 more source

Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data

British Journal of Clinical Pharmacology, EarlyView.
Aim Pancreatic enzyme replacement therapy (PERT) is essential for the management of pancreatic exocrine insufficiency. Since June 2023, the United Kingdom has been affected by a global shortage of PERT. We investigated the impact of this shortage on national prescribing trends for Creon, Nutrizym, Pancrex and Pangrol.
Teena S. Varghese, Mary E. Phillips, Louis Fisher, Helen Fitt, Adam Frampton, Christopher Wood, Agnieszka Lemanska   +6 more
wiley   +1 more source

Absorption, distribution, metabolism and excretion of londamocitinib after single‐dose inhaled, intravenous and oral administration in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aim Londamocitinib (AZD4604) is an inhaled, selective Janus kinase 1 (JAK1) inhibitor in development for asthma. This open‐label, two‐part, phase I clinical study (NCT06157255) used a radiolabelled microtracer approach to evaluate the absolute bioavailability and the absorption, distribution, metabolism and excretion (ADME) of inhaled londamocitinib ...
Camille Riff, Peter Bold, Maria Heijer, Ryan A. Bragg, Danielle Steele, Tina Jellesmark Jensen, Davinder P. S. Dosanjh, Sabrina I. Hanswijk‐Bartelds, Esther van Duijn, Elwin R. Verheij, Somasekhara Menakuru, Rod Hughes, Helena Dahlbäck   +12 more
wiley   +1 more source